Rezolute, Inc. - Common Stock, par value $0.001 per share (RZLT)

CUSIP: 76200L309

Q1 2021 13F Holders as of 31 Mar 2021

Holder snapshot 6 signals
Share change
-29,320
SEC-reported price per share
$7.06
Indexed holders
10
Value change
-$208,256
Number of buys
5
Number of sells
3
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
118,102,557

Security key

76200L309

Report period

Q1 2021

Indexed institutions

10

Top holders

8

Ownership snapshot

Top reported holders of RZLT - Rezolute, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Genexine Inc.
Disclosed value leader
Genexine Inc.
Comparable rows
0/8
Latest evidence
31 Dec 2020
3/4/5 13F Highest disclosed value: $173,462,643 8 rows are not safely comparable across share classes. Showing 1-6 of 8 holder rows.

Quick read

Genexine Inc. has the largest disclosed position value at $173.46M.

0 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Genexine Inc.'s linked filing trail.
Disclosed position value Top 5
Genexine Inc. $173.46M
FEDERATED HERMES, INC. $14.53M
CAXTON CORP $5.09M
ARMISTICE CAPITAL, LLC $4M
CITADEL ADVISORS LLC $3.76M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 8 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Genexine Inc.
3/4/5
10%+ Owner
—
denominator unverified
$173,462,643
91,300,933 shares
— 26 Apr 2019
FEDERATED HERMES, INC.
13F
Company
13F
—
denominator unverified
$14,533,000
1,212,122 shares
— 31 Dec 2020
CAXTON CORP
13F
Company
13F
—
denominator unverified
$5,087,000
424,243 shares
— 31 Dec 2020
ARMISTICE CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$4,005,000
333,990 shares
— 31 Dec 2020
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$3,757,000
304,231 shares
— 31 Dec 2020
BVF INC/IL
13F
Company
13F
—
denominator unverified
$2,357,000
190,814 shares
— 31 Dec 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
10
Shares
2,477,026
Indexed holders
10
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 indexed holders
7
Q1 2021 indexed holders
10
Indexed holder difference
3
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 value Q1 2021 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .